Ryuichi Moriya

Head, Biologics Engineering Astellas Pharma

Seminars

Monday 3rd November 2025
Learning From the Past & Harnessing Design Innovation to Develop a New Wave of ADCs
10:00 am
  • Contextualizing success from cytotoxic ADC development, headlined by the approval and success of Padcev
  • Re-envisioning ADC design through collaboration on dual payload ADC development
  • Demonstrating ADC payload innovation through degrader antibody conjugate programs
Ryuichi Moriya - 16th World ADC San Diego